Drug Trial Radar · NCT02609399
ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir
Last checked: Nov 20, 2026Latest source record: Oct 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
180
Actual
Start
Nov 1, 2015
Primary completion
May 26, 2017
Study completion May 31, 2018
Sponsor
- Lead sponsor
- Johns Hopkins UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Department of Health and Human Services
- First posted
- Nov 20, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot study is designed to demonstrate the feasibility of utilizing Emergency Departments (EDs) as a primary site for subject enrollment in clinical trials evaluating influenza therapeutics, and to provide pilot data for future clinical trial design and planning. Primary Objective: To prospectively enroll high-risk subjects with laboratory-confirmed influenza into a randomized, open label study of oral versus IV influenza therapeutic to include symptom evaluation and outcome assessments. Secondary Objective 1: To identify influenza positive patients utilizing a previously established triage-based assessment and rapid testing algorithm for suspected influenza infection. Secondary Objective 2: To retrospectively evaluate all potentially eligible patients for potential enrollment biases. Secondary Objective 3: To create a repository of residual nasopharyngeal samples collected from ED patients with suspected influenza illness.
Conditions
- Influenza
Interventions
OseltamivirDrug
Oral
PeramivirDrug
IV Note: Subjects admitted to the hospital directly from the ED Enrollment Visit may receive more doses at the discretion of the treating physician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Symptom Severity Score During the 2015-2016 Influenza Season for Symptom Domains as Assessed Using the Influenza-Patient Reported Outcome (FLU-PRO™) QuestionnaireTime frame: ED Enrollment Visit through Day 14 ( 2015-2016 influenza season)
- Mean Symptom Severity Score During the 2016-2017 Influenza Season for Symptom Domains as Assessed Using the FLU-PRO™ QuestionnaireTime frame: ED Enrollment Visit through Day 14 ( 2016-2017 influenza season)
- Mean Karnofsky Performance Scale Score During the 2015-2016 Influenza SeasonTime frame: ED Enrollment Visit through Day 14 ( 2015-2016 influenza season)
- Mean Karnofsky Performance Scale Score During the 2016-2017 Influenza SeasonTime frame: ED Enrollment Visit through Day 14 ( 2016-2017 influenza season)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Maricopa Integrated Health System
Phoenix, Arizona
Johns Hopkins Hospital
Baltimore, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.